88377948 - ARRNA

Information

  • Trademark
  • 88377948
  • Serial Number
    88377948
  • Filing Date
    April 09, 2019
    5 years ago
  • Transaction Date
    January 06, 2020
    4 years ago
  • Status Date
    January 06, 2020
    4 years ago
  • Location Date
    January 06, 2020
    4 years ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 127 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    MCCARTHY, JOSEPH PATRI
  • Attorney Name
    Gregory F. Buhyoff
    Law Office Assigned Location Code
    N90
  • Owners
Mark Drawing Code
4000
Mark Identification
ARRNA
Case File Statements
  • GS0011: Cell culture reagents for scientific and research use; Cells for scientific, laboratory or medical research; Reagents for scientific or medical research use; Assays and reagents for use in genetic research; Diagnostic reagents for scientific use
  • GS0051: Cells for medical or clinical use; Pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; Pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals, namely, antifungal preparations, dermatological preparations, smoking cessation preparations and tissue repair preparations in the nature of biological tissue grafts; Diagnostic reagents for medicinal use
  • GS0421: Medical and scientific research in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Medical and scientific research information in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics
Case File Event Statements
  • 1/6/2020 - 4 years ago
    8 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2
  • 1/6/2020 - 4 years ago
    7 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 6/21/2019 - 5 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/21/2019 - 5 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/21/2019 - 5 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/19/2019 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/26/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 4/12/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP